An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients

Jianqing Lin, Aileen Deng, Jean Hoffman-Censits, Geoffrey Gibney, Terry Hyslop, Brooke Miller, Deborah Kilpatrick, Serge Jabbour, William Kevin Kelly

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences